-transparent.png){kind=logo}
Long-term adjuvant immunochemotherapy carried out on the gastrectomized patients with stomach cancer was reported. The protocol comprises the administration of large-dose of Mitomycin-C (20+10) mg just after gastrectomy and the long-term administration of PSK, FT-207 or (PSK+FT-207). Almost no side effects were observed. According to the studies on the immunological parameters, the increased reactions in PPD skin test and lymphocyte blastogenesis induced by PHA and PWM were observed remarkably in group (P+F) 3 or 6 months after gastrectomy. As for the survival rate, group (P+F) showed the most preferable results at one year in stage IV, at two years in stage III and at three years in all the stages, respectively after gastrectomy.
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
August 1988,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
January 1990,
Gan no rinsho. Japan journal of cancer clinics,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
January 1984,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
March 1990,
The Japanese journal of surgery,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
January 1993,
Cancer chemotherapy and pharmacology,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
May 1994,
Lancet (London, England),
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
May 1978,
International journal of clinical pharmacology and biopharmacy,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
August 1981,
Nihon Gan Chiryo Gakkai shi,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
August 2008,
Cancer biotherapy & radiopharmaceuticals,
T Hattori, and
M Niimoto, and
T Koh, and
A Nakano, and
M Oride, and
W Takiyama, and
K Nishimawari
October 1982,
The Tohoku journal of experimental medicine,
